#USA #Boca Raton #Florida Cancer Specialists #Carlos Barbur #oncology service

Florida Cancer Specialists Welcomes Dr. Carlos Barbur

Florida Cancer Specialists & Research Institute (FCS) has bolstered its medical team with the addition of Dr. Carlos Barbur, a highly qualified and board-certified medical oncologist and hematologist. This decision comes as part of FCS's commitment to meet the increasing demand for advanced cancer care in the community. Dr. Barbur will be seeing patients in both the Boca Raton office located at 21020 State Road 7, Suite 200C, Boca Raton, FL 33428, and the Delray Beach location at 5130 Linton Blvd, Suite B4, Delray Beach, FL 33484-6595.

Enhancing Local Care Accessibility

As communities become increasingly aware of the critical importance of personalized cancer treatment, the introduction of Dr. Barbur is a strategic move to provide enhanced access to expert care. His background includes extensive training and experience in diagnosing and treating various cancers and blood disorders, ensuring that local patients receive the highest level of medical attention.

David Wenk, MD, who serves as the assistant managing physician at FCS, expressed enthusiasm about Dr. Barbur's addition, emphasizing that it will strengthen their capability to deliver timely and high-quality care. He stated, “Dr. Barbur’s expertise in cancer and blood disorders, along with his dedication to patient-centered treatment, will significantly enhance the quality of services we offer.”

Dr. Barbur's Background and Expertise

Dr. Barbur holds a Doctor of Osteopathic Medicine degree from Nova Southeastern University in Fort Lauderdale, Florida. After completing his residency in internal medicine at Palmetto General Hospital in Hialeah, he further honed his skills with a fellowship in hematology and oncology at Larkin Community Hospital – Palm Springs Campus in Hialeah. He is board-certified in internal medicine, hematology, and medical oncology, which positions him as a well-rounded physician ready to tackle a wide spectrum of oncologic and hematologic issues.

Personalized Treatment Plans

What sets Dr. Barbur apart is his commitment to developing individualized treatment plans. He collaborates closely with multidisciplinary teams, integrating the latest advancements in cancer care to ensure tailored approaches for each patient’s needs. These plans take into account the specific type of cancer or blood disorder, the patient’s overall health, and their personal preferences. This comprehensive approach not only aims to improve patient outcomes but also provides emotional support during challenging treatment journeys.

Scheduling Appointments

Patients interested in receiving care from Dr. Barbur can easily schedule appointments by contacting the offices directly. For Boca Raton, call (561) 409-1071, or for Delray Beach, dial (561) 808-0098. This level of accessibility is a vital step in achieving FCS's goal of delivering world-class cancer care in a community setting.

About Florida Cancer Specialists & Research Institute

Established over 40 years ago, FCS has built its reputation on innovation and advanced oncology treatment. The organization is known for integrating cutting-edge practices within its clinical research programs, which include numerous active clinical trials. FCS collaborates with the Sarah Cannon Research Institute (SCRI), allowing patients access to innovative therapies typically available only in clinical trials.

Through this dedication to clinical research and patient-centered care, FCS aims to drive the transformation of oncology and provide groundbreaking cancer therapies that elevate patient care. FCS is recognized as a leader among oncology practices across Florida and the United States.

As Dr. Barbur joins this esteemed team, patients can expect enhanced service and a commitment to their health and well-being, making a significant impact on community cancer care. FCS is excited to see how Dr. Barbur’s contributions will continue to push the boundaries of advanced cancer treatment within the community.